Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA pseudouridine synthase domain containing 1 (RPUSD1) is a protein-coding enzyme predicted to catalyze pseudouridine synthase activity—specifically, the isomerization of uridine to pseudouridine in ribosomal RNA (rRNA)[1]. RPUSD1 is part of the larger family of pseudouridine synthases, which modify RNA by converting uridine bases to pseudouridine, a process crucial for stabilizing RNA conformations and influencing ribosome structure and function[2]. RPUSD1, like other pseudouridine synthases, contains an RNA-binding domain and a highly conserved catalytic aspartate necessary for its enzymatic activity[2]. These enzymes play essential roles in ribosome biogenesis, RNA maturation, and translation fidelity. No direct small molecule inhibitors, clinical drugs, or routine biomarkers are currently reported for RPUSD1, and its roles in human disease remain unclear; however, similar enzymes have been linked to defects in protein synthesis and cellular disease phenotypes[2].
Blockade of pseudouridine synthase catalytic activity (prevents uridine isomerization in rRNA).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA pseudouridine synthase domain containing 1 (RPUSD1).